查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974212

输液帮浦及配件市场：按产品、操作方式、应用和最终用户划分 - 2026-2032年全球预测

Infusion Pumps & Accessories Market by Product, Operation, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，输液帮浦及配件市场价值将达到 192 亿美元，到 2026 年将成长至 206.8 亿美元，到 2032 年将达到 332.1 亿美元，复合年增长率为 8.14%。

主要市场统计数据
基准年 2025 192亿美元
预计年份：2026年 206.8亿美元
预测年份 2032 332.1亿美元
复合年增长率 (%) 8.14%

输液帮浦及其配件在临床安全、互联互通和居家照护转型中占据核心地位，被认为是影响医疗设备。

输液帮浦及配件产业正处于临床需求、技术创新和不断发展的医疗服务模式的交汇点。随着在医院、诊所和家庭中精准输注治疗变得日益重要，兼具可靠性、连接性和以患者为中心的设计理念的设备已从辅助组件转变为医疗服务流程的核心组成部分。本文将此类别置于更广泛的医疗保健需求框架下进行探讨：提高安全性、加强门诊和居家护理，以及支援数据驱动的临床决策。

简明扼要地整合了关键的变革性转变，这些转变重新定义了整个输液泵生态系统中的产品设计、护理服务环境和监管要求。

由于三大因素的共同作用，输液帮浦及相关设备的市场格局正在改变：技术成熟、医疗服务分散化以及监管和网路安全力度加大。医疗设备製造商正在整合先进的感测器、更智慧的韧体和无线连接功能，使输液泵能够提供更丰富的遥测数据、实现远端滴定并与临床决策支援系统整合。因此，软体更新路径、互通性认证和以使用者为中心的设计在医疗设备的整个生命週期中都成为优先事项，旨在减轻医护人员的负担并最大限度地减少治疗错误。

对 2025 年美国实施的关税调整对供应链、采购和製造选择的累积营运和策略影响进行重点分析。

2025 年美国关税环境为製造商、供应商和医疗保健机构带来了新的营运挑战，影响采购、供应商选择和整体生产策略。关税调整提高了总到岸成本的透明度，迫使企业重新评估其供应商布局和原材料投入。拥有全球供应链的製造商正透过多元化零件来源、尽可能增加在地采购以及与值得信赖的供应商签订长期合约来降低波动风险。这种调整需要对替代供应商进行认证、进行额外的品质审核，并分配资金以确保紧急储备，从而维持生产的连续性。

将产品类型、操作等级、临床应用和最终用户需求与不断变化的商业性和临床重点联繫起来的详细細項分析。

细分市场层面的趋势揭示了每个产品类型、操作模式、临床应用和终端用户环境所面临的微妙机会和营运挑战。按产品划分，市场可分为配件和耗材以及输液帮浦。在输液帮浦领域，携带式输液帮浦、肠道餵食帮浦、植入式输液帮浦、胰岛素输液帮浦、病人自控镇痛帮浦、注射器式输液帮浦和容积式输液帮浦各自反映了不同的应用场景、生命週期预期和服务模式。携带式输液帮浦和胰岛素帮浦优先考虑便携性、用药依从性支援和电池管理，而植入式输液帮浦和容积式输液帮浦则优先考虑长期可靠性、精准给药以及与手术或住院患者的整合。配件和耗材是持续收入的来源，需要强大的物流和无菌保证。

关键区域洞察显示医疗保健系统、法规环境和医疗保健服务模式的差异如何影响设备部署、供应策略和商业性方法。

区域趋势表明，输液帮浦及其配件的需求驱动因素和普及管道因地区而异，反映了医疗基础设施、管理体制和医疗服务模式的差异。在美洲，完善的报销体系、对患者安全的高度重视以及互联设备的快速普及正在影响着输液泵及其配件的普及，因此供应商必须证明其产品能够与电子健康记录集成，并提供强大的服务网络。相较之下，在欧洲、中东和非洲，复杂的监管环境和各国不同的政策导致了需求的多样性，这更有利于模组化产品平台和灵活的分销策略。供应商通常会在认证、培训和上市后监管方面采用区域性模式。

竞争动态的策略概述：强调产品差异化、服务品质、伙伴关係和证据生成是关键的成功因素。

输液帮浦及配件产业的动态取决于技术差异化、服务能力、临床证据产生和分销网络拓展的综合因素。拥有强大的产品系列组合、完善的售后支援和整合软体平台的公司，在与医疗机构签订合约和支援长期治疗方案方面更具优势。医疗设备製造商与数位医疗公司之间的策略合作，正在将分析能力的提供范围扩展到硬体、远端监测和用药依从性计划之外，从而增加了转型成本，并创造了新的、持续的收入来源。

为製造商、医疗保健提供者和采购团队提供实用建议，将策略见解转化为强大的产品策略、筹资策略和实证方法。

产业领导者应采取一系列切实可行的积极措施，将洞察转化为可衡量的优势。首先，互通性和网路安全应作为核心产品功能而非附加功能进行投资，以确保医疗设备能够与医院系统和远端医疗平台安全地交换资料。其次，应扩展服务和支援范围，包括远端监控、预防性保养和临床医生培训方案，以减少中断并提高客户终身价值。第三，应实现采购多元化，探索区域製造和伙伴关係模式，以降低关税波动和运输中断带来的风险，同时制定紧急库存策略，以确保供应的连续性。

本执行摘要清楚地解释了多方面的调查方法，该方法结合了初步访谈、文献综述和专家检验，以确保获得扎实的实践知识。

本执行摘要的研究结合了初步访谈、二手文献分析、仪器文件审查​​以及跨领域专家检验，以确保全面平衡的观点。初步资讯是透过对临床医生、生物医学工程师、采购经理和行业高管的结构化访谈收集的，旨在了解实际应用中的挑战和实际性能方面的考虑。二手分析包括监管申报文件、产品手册和同行评审的临床研究，以支持安全性、易用性和技术特性的论点。

一项权威的综合分析证实了互通性、服务和弹性如何结合起来，从而在整个输液泵生态系统中推动临床价值和商业性成功。

总之，输液帮浦及相关设备是现代医疗安全改进、居家医疗以及将治疗服务与数位健康平台整合的关键所在。该领域正从独立设备转向涵盖硬体、软体和持续支援的服务型解决方案。这一趋势有利于那些能够提供无缝互通性、显着临床价值和可靠服务网络的公司。近期政策週期、关税趋势和供应链压力进一步加剧了对多元化采购和增强营运韧性的需求。同时，不同地区在监管和医疗服务体系上的差异也要求企业采取适应性强的商业化策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 输液帮浦及配件市场：依产品分类

  • 配件和耗材
  • 点滴帮浦
    • 家用输液泵
    • 肠道餵食帮浦
    • 植入式输液泵
    • 胰岛素输注泵
    • 患者自控镇痛泵
    • 注射帮浦
    • 定量注射泵

第九章 输液帮浦及配件市场：依操作方式划分

  • 电的
  • 机械驱动

第十章 输液帮浦及配件市场：依应用领域划分

  • 糖尿病管理
  • 胃肠病学
  • 血液学
  • 神经病学
  • 肿瘤学
  • 疼痛管理

第十一章 输液帮浦及配件市场：依最终用户划分

  • 学术和研究机构
  • 门诊部
  • 居家医疗
  • 医院和诊所

第十二章 输液帮浦及配件市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 输液帮浦及配件市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 输液帮浦及配件市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国输液帮浦及配件市场

第十六章：中国输液帮浦及配件市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Avanos Medical, Inc.
  • B. Braun SE
  • Baxter International, Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cane SpA
  • Chemyx Inc.
  • Eitan Medical
  • Epic Medical Pty Ltd.
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Freudenberg Group
  • FUJIFILM Corporation
  • ICU Medical, Inc.
  • IRadimed Corporation
  • Medtronic plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • Narang Medical Limited
  • Nipro Corporation
  • Omnipod by Insulet Corporation
  • SAI Infusion Technologies
  • Shenzhen Hawk Medical Instrument Co., Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • TERUMO CORPORATION
  • Thermo Fisher Scientific Inc.
  • Ypsomed AG
Product Code: MRR-3B3453376B7D

The Infusion Pumps & Accessories Market was valued at USD 19.20 billion in 2025 and is projected to grow to USD 20.68 billion in 2026, with a CAGR of 8.14%, reaching USD 33.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.20 billion
Estimated Year [2026] USD 20.68 billion
Forecast Year [2032] USD 33.21 billion
CAGR (%) 8.14%

An authoritative introduction positioning infusion pumps and accessories at the center of clinical safety, connectivity, and home-based care transformations shaping device adoption

The infusion pump and accessories domain is at the intersection of clinical need, technological innovation, and shifting care delivery models. As hospitals, clinics, and homes increasingly demand precise delivery of therapies, devices that combine reliability with connectivity and patient-centric design have moved from adjuncts to central components of care pathways. This introduction situates the category within broader healthcare imperatives: improving safety, enabling ambulatory and home-based treatments, and supporting data-driven clinical decisions.

Over the past several years, incremental improvements in hardware have been complemented by leaps in software and connectivity. Consequently, infusion systems are no longer simply mechanical or electrical instruments; they are nodes in clinical information networks that must interoperate with electronic records and remote monitoring platforms. This shift has implications for procurement, clinical protocols, and vendor selection, as institutions weigh durability and warranty coverage alongside cybersecurity, interoperability, and usability. Furthermore, as patient populations age and chronic disease prevalence rises, the demand for devices that support long-term therapy adherence and minimize caregiver burden intensifies.

Finally, evolving regulatory expectations and reimbursement frameworks are reshaping how manufacturers design devices and how healthcare providers justify capital and operational expenditures. Together, these drivers create an environment where clinical efficacy, human factors, and systems integration define value. The remainder of this executive summary builds from this foundational context to examine transformative shifts, policy impacts, segmentation dynamics, regional differentiators, competitive positioning, recommended actions, and the methods used to assemble these insights.

A concise synthesis of the major transformative shifts redefining product design, care delivery settings, and regulatory expectations across infusion pump ecosystems

The landscape for infusion pumps and accessories is undergoing transformative shifts driven by three converging forces: technology maturation, care-delivery decentralization, and heightened regulatory and cybersecurity scrutiny. Device manufacturers are embedding advanced sensors, smarter firmware, and wireless connectivity so pumps can provide richer telemetry, enable remote titration, and integrate with clinical decision support. As a result, device lifecycles now prioritize software update pathways, interoperability certifications, and user-centered designs to minimize clinician burden and reduce therapy errors.

Simultaneously, patient care is moving beyond the hospital. Ambulatory infusion pumps and devices designed for home use are expanding the range of therapies delivered outside traditional settings. This movement alters value propositions; payers and providers increasingly prioritize total cost of care, patient satisfaction, and reduced readmissions. Therefore, vendors must demonstrate outcomes and support services that enable safe decentralization of complex therapies. Transitioning therapies out of inpatient wards also requires changes in training, remote monitoring, and supply chain reliability to ensure continuity of care.

Finally, regulatory landscapes and cybersecurity expectations have intensified. Stakeholders now demand robust risk management, timely vulnerability mitigation, and clear pathways for software maintenance and field updates. These pressures favor larger vendors with established quality systems, while also creating opportunities for niche players who can demonstrate strong clinical evidence and integration capabilities. In sum, the market is shifting from isolated device sales toward bundled offerings that combine hardware, software, and services to meet evolving clinical and operational needs.

A focused analysis of the cumulative operational and strategic effects that United States tariff adjustments in 2025 imposed on supply chains, procurement, and manufacturing choices

The 2025 United States tariff environment has introduced new operational considerations for manufacturers, suppliers, and healthcare providers that reverberate across procurement, sourcing, and manufacturing strategies. Tariff adjustments have increased the visibility of total landed cost and compelled organizations to reassess supplier footprints and material inputs. Manufacturers with globalized supply chains have responded by diversifying component sourcing, increasing localization where feasible, and negotiating longer-term agreements with trusted suppliers to mitigate volatility. This recalibration has required capital allocation toward alternative supplier qualification, additional quality audits, and contingency inventory to preserve production continuity.

For providers and group purchasing organizations, the tariff context elevates the importance of contract terms and supply chain transparency. Procurement teams are placing renewed emphasis on clauses that address cost pass-throughs, lead-time variability, and product substitution. At the same time, clinicians and biomedical teams are working with vendors to manage service continuity as manufacturers adapt component procurement or revise product configurations. These adjustments have sometimes led to temporary SKU rationalizations or delayed product launches as companies work through compliance and cost pressures.

Moreover, the tariff environment has accelerated conversations around onshoring and nearshoring for critical components and accessories. While reshoring can reduce exposure to cross-border tariffs and shipping disruptions, it also demands investment in domestic manufacturing capacity and the development of local supplier ecosystems. In parallel, manufacturers are investing in tooling and process improvements to offset higher input costs through efficiency gains. Ultimately, the cumulative impact of tariff changes in 2025 has been to intensify supply chain resilience planning, drive procurement and product strategy realignment, and prioritize transparency across the value chain so that healthcare organizations and manufacturers can jointly manage cost and continuity risks.

In-depth segmentation insights linking product categories, operational classes, clinical applications, and end-user requirements to evolving commercial and clinical priorities

Segment-level dynamics reveal nuanced opportunities and operational challenges across product categories, modes of operation, clinical applications, and end-user settings. Based on Product, the market is studied across Accessories & Consumables and Infusion Pumps; within Infusion Pumps, Ambulatory Infusion Pumps, Enteral Feeding Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps reflect distinct clinical use cases, lifecycle expectations, and service models. Ambulatory and insulin pumps emphasize portability, adherence support, and battery management, whereas implantable and volumetric systems prioritize long-term reliability, precision dosing, and surgical or inpatient integration. Accessories and consumables drive recurring revenue streams and require robust logistics and sterilization assurances.

Based on Operation, the market is studied across Electrically Operated and Mechanically Operated devices, and each operational class carries different maintenance regimes, training requirements, and failure-mode profiles. Electrically operated systems increasingly include software-driven fail-safes and remote telemetry, which augment performance but also introduce cybersecurity and update management needs. Mechanically operated pumps, often valued for simplicity and reliability, remain relevant in constrained environments and as backup systems where electronic complexity is impractical.

Based on Application, the market is studied across Diabetes Management, Gastroenterology, Hematology, Neurology, Oncology, and Pain Management, each of which imposes unique dosing regimens, monitoring needs, and payer considerations. Diabetes management and oncology therapies, in particular, demand tight adherence and integration with patient monitoring to optimize outcomes. Finally, Based on End-User, the market is studied across Academic & Research Institutes, Ambulatory Care Settings, Home Care, and Hospitals & Clinics, with each end-user segment prioritizing different procurement cycles, service agreements, and training investments. Academic centers and hospitals focus on feature-rich, interoperable systems, while home care emphasizes ease of use and remote support.

Key regional insights demonstrating how differing healthcare systems, regulatory environments, and care delivery models shape device adoption, supply strategies, and commercial approaches

Regional patterns demonstrate that demand drivers and adoption pathways for infusion pumps and accessories vary markedly across geographies, reflecting differences in healthcare infrastructure, regulatory regimes, and care delivery models. In the Americas, adoption is shaped by sophisticated reimbursement frameworks, a strong emphasis on patient safety, and rapid uptake of connected devices, which together encourage vendors to demonstrate integration with electronic medical records and to provide robust service networks. By contrast, regulatory complexity and divergent national policies across Europe, Middle East & Africa create a patchwork of requirements that favor modular product platforms and flexible distribution strategies; vendors often deploy regionally tailored models for certification, training, and post-market surveillance.

Asia-Pacific exhibits a mix of rapid public and private investment in hospital modernization, expanding access to home-based care, and a broad spectrum of clinical practice patterns. These dynamics create both scale opportunities and the need for localized approaches to pricing and training. Across all regions, telehealth expansion and workforce constraints are convergent trends that shape product value propositions: devices that reduce clinician workload and enable remote management gain traction universally. In addition, regional supply chain considerations, currency movements, and local manufacturing incentives influence where companies invest in capacity and how they structure distribution agreements. Therefore, geographic strategy must balance global product consistency with local regulatory, clinical, and commercial adaptations.

A strategic overview of competitive dynamics emphasizing product differentiation, service excellence, partnerships, and evidence generation as key success factors

Competitive dynamics in the infusion pump and accessories space are defined by a blend of technological differentiation, service capabilities, clinical evidence generation, and distribution reach. Companies that combine robust product portfolios with strong post-sale support and integrated software platforms are better positioned to win institutional contracts and to support long-term therapy pathways. Strategic partnerships between device manufacturers and digital health firms are expanding offerings beyond hardware to include analytics, remote monitoring, and adherence programs, thereby creating higher switching costs and new avenues for recurring revenue.

At the same time, smaller and more specialized vendors are leveraging niche clinical expertise and agile development cycles to address unmet needs, such as compact ambulatory devices or accessories optimized for low-resource settings. These players can be attractive partners for larger firms seeking innovation without incurring the full R&D expense. Moreover, service differentiation-such as rapid field response, extended warranties, and clinician training-remains a critical competitive lever, particularly as institutions emphasize uptime and total cost of ownership.

Finally, intellectual property around infusion algorithms, safety interlocks, and interoperability standards contributes to competitive barriers. Companies that invest in clinical studies and real-world evidence can more credibly demonstrate outcomes and justify premium positioning. Given these dynamics, market participants need to balance product innovation with scalable service models and evidence generation to sustain growth and defend market positions.

Actionable recommendations for manufacturers, providers, and procurement teams that translate strategic insights into resilient product, sourcing, and evidence-driven approaches

Industry leaders should adopt a set of pragmatic, forward-looking actions to convert insights into measurable advantage. First, invest in interoperability and cybersecurity as core product features rather than add-ons, ensuring devices can securely exchange data with hospital systems and telehealth platforms. Second, expand service and support offerings to include remote monitoring, preventive maintenance, and clinician training bundles that reduce operational disruption and increase customer lifetime value. Third, diversify sourcing and consider regional manufacturing or partnership models to reduce exposure to tariff volatility and shipping disruptions, while simultaneously developing contingency inventory strategies to preserve continuity of supply.

In parallel, companies should accelerate evidence generation through post-market studies and real-world data initiatives that link device performance to clinical outcomes and cost metrics. This evidence supports procurement discussions, payer conversations, and clinician adoption. Engage with frontline clinicians early in the design and deployment process to refine human factors and minimize training burdens. Finally, evaluate business models that combine hardware, consumables, and services into subscription or managed-service offerings that align incentives across manufacturers, providers, and payers. By focusing on these priority actions, leaders can strengthen resilience, improve clinical value, and capture new revenue streams as care delivery continues to evolve.

A transparent description of the multi-method research approach combining primary interviews, documentation review, and expert validation to ensure robust and actionable insights

The research underpinning this executive summary combines primary interviews, secondary literature analysis, device documentation review, and cross-functional expert validation to ensure a comprehensive and balanced perspective. Primary input was obtained through structured interviews with clinicians, biomedical engineers, procurement leaders, and industry executives to capture practical implementation challenges and real-world performance considerations. Secondary analysis included regulatory filings, product manuals, and peer-reviewed clinical studies to corroborate claims about safety, usability, and technological features.

Where possible, device specifications and post-market notices were reviewed to assess maintenance requirements, software update pathways, and interoperability claims. The research team triangulated findings across sources and used subject-matter workshops to test hypotheses about adoption drivers and competitive positioning. Limitations include the rapid pace of technological change and potential variability in local regulatory interpretations; therefore, findings emphasize durable trends and qualitative insights rather than short-term fluctuations. Transparency in method and an emphasis on cross-validation provide confidence that the conclusions and recommendations are practical and relevant for decision-makers engaged in procurement, clinical integration, or strategic planning.

A conclusive synthesis reinforcing how interoperability, services, and resilience combine to drive clinical value and commercial success across infusion pump ecosystems

In conclusion, infusion pumps and accessories are central to contemporary efforts to improve medication safety, enable home-based care, and integrate therapeutic delivery with digital health platforms. The sector is shifting from standalone devices to services-oriented solutions that bundle hardware, software, and ongoing support, a trend that rewards companies capable of delivering seamless interoperability, demonstrable clinical value, and reliable service networks. Tariff dynamics and supply chain pressures in recent policy cycles have reinforced the need for diversified sourcing and operational resilience, while regional differences in regulation and care delivery require adaptive commercialization strategies.

To translate these macro trends into operational success, stakeholders must prioritize interoperability, invest in real-world evidence generation, and structure service offerings that reduce clinician workload and enhance patient adherence. By doing so, manufacturers and providers can both improve clinical outcomes and create sustainable business models that respond to evolving payer and regulatory expectations. The insights presented here are intended to support informed decision-making across product development, procurement, and clinical adoption, helping organizations to navigate complexity and to seize opportunities in a rapidly changing landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Infusion Pumps & Accessories Market, by Product

  • 8.1. Accessories & Consumables
  • 8.2. Infusion Pumps
    • 8.2.1. Ambulatory Infusion Pumps
    • 8.2.2. Enteral Feeding Pumps
    • 8.2.3. Implantable Infusion Pumps
    • 8.2.4. Insulin Infusion Pumps
    • 8.2.5. Patient-Controlled Analgesia Pumps
    • 8.2.6. Syringe Infusion Pumps
    • 8.2.7. Volumetric Infusion Pumps

9. Infusion Pumps & Accessories Market, by Operation

  • 9.1. Electrically Operated
  • 9.2. Mechanically Operated

10. Infusion Pumps & Accessories Market, by Application

  • 10.1. Diabetes Management
  • 10.2. Gastroenterology
  • 10.3. Hematology
  • 10.4. Neurology
  • 10.5. Oncology
  • 10.6. Pain Management

11. Infusion Pumps & Accessories Market, by End-User

  • 11.1. Academic & Research Institutes
  • 11.2. Ambulatory Care Settings
  • 11.3. Home Care
  • 11.4. Hospitals & Clinics

12. Infusion Pumps & Accessories Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Infusion Pumps & Accessories Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Infusion Pumps & Accessories Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Infusion Pumps & Accessories Market

16. China Infusion Pumps & Accessories Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avanos Medical, Inc.
  • 17.6. B. Braun SE
  • 17.7. Baxter International, Inc.
  • 17.8. Bayer AG
  • 17.9. Becton, Dickinson, and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. Cane S.p.A.
  • 17.12. Chemyx Inc.
  • 17.13. Eitan Medical
  • 17.14. Epic Medical Pty Ltd.
  • 17.15. F. Hoffmann-La Roche AG
  • 17.16. Fresenius SE & Co. KGaA
  • 17.17. Freudenberg Group
  • 17.18. FUJIFILM Corporation
  • 17.19. ICU Medical, Inc.
  • 17.20. IRadimed Corporation
  • 17.21. Medtronic plc
  • 17.22. Micrel Medical Devices SA
  • 17.23. Moog Inc.
  • 17.24. Narang Medical Limited
  • 17.25. Nipro Corporation
  • 17.26. Omnipod by Insulet Corporation
  • 17.27. SAI Infusion Technologies
  • 17.28. Shenzhen Hawk Medical Instrument Co., Ltd
  • 17.29. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.30. Tandem Diabetes Care, Inc.
  • 17.31. Teleflex Incorporated
  • 17.32. TERUMO CORPORATION
  • 17.33. Thermo Fisher Scientific Inc.
  • 17.34. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ENTERAL FEEDING PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INSULIN INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ELECTRICALLY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY MECHANICALLY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 129. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 147. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 148. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 152. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 153. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 154. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY OPERATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA INFUSION PUMPS & ACCESSORIES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)